SBFM
Sunshine Biopharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 1
Consensus Rating "Strong Buy"
Ample Liquidity
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About SBFM
Sunshine Biopharma, Inc.
A pharmaceutical company focused on the oncology and antiviral drugs
Pharmaceutical
08/31/2006
02/15/2022
NASDAQ Stock Exchange
52
12-31
Common stock
1177 Avenue of the Americas, 5th Floor, New York, NY 10036
--
Sunshine Biopharma, Inc., was incorporated in Colorado on August 31, 2006. The company is a pharmaceutical company that provides and researches life-saving drugs in a wide range of therapeutic areas, including oncology and antiviral drugs.
Company Financials
EPS
SBFM has released its 2025 Q3 earnings. EPS was reported at -0.19, versus the expected -0.13, missing expectations. The chart below visualizes how SBFM has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
SBFM has released its 2025 Q3 earnings report, with revenue of 9.42M, reflecting a YoY change of 11.64%, and net profit of -883.82K, showing a YoY change of 26.21%. The Sankey diagram below clearly presents SBFM's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
